Macy Burkhart|
Erin Garza joined the MJ team as a risk transfer specialist in our Risk Management + Commercial Insurance department. In this role, Erin is responsible for working closely with the analytics, risk services, and client advocacy teams to develop risk transfer strategies. These strategies consist of coordinating service and marketing activities, inspecting data for potential coverage gaps and making the necessary recommendations on those limitations that correlate best with the needs of her clients.
Prior to MJ, Erin acquired over six years of experience working in the insurance industry in roles such as assistant vice president of multinational account manager and Commercial Line account manager. Her drive and dedication to providing clients with the best solution for their insurance needs make Erin a valuable asset to the MJ team.
Related Blogs
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
DeAnn DeckOn Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
DOL Issues Updated Model Employer CHIP Notice
DeAnn DeckThe U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Prescription Drug Reporting (RxDC Report)
DeAnn DeckThe No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More